Lv1
70 积分 2025-10-14 加入
Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes
12天前
已完结
Liraglutide or insulin glargine treatments improves hepatic fat in obese patients with type 2 diabetes and nonalcoholic fatty liver disease in twenty-six weeks: A randomized placebo-controlled trial
12天前
已完结
The Effects of GLP-1 Receptor Agonists on Body Composition in Patients with Type 2 Diabetes, Overweight or Obesity: A Meta-Analysis of Randomized Controlled Trials
18天前
已完结
The effect of SGLT2 inhibitors, GLP1 agonists, and their sequential combination on cardiometabolic parameters: A randomized, prospective, intervention study
19天前
已完结
Effects of retatrutide on body composition in people with type 2 diabetes: a substudy of a phase 2, double-blind, parallel-group, placebo-controlled, randomised trial
19天前
已完结
Omega-3 polyunsaturated fatty acids in sarcopenia management: A network meta-analysis of randomized controlled trials
20天前
已完结
Compassionate care in obesity management: reclaiming humanity in health care
1个月前
已完结
Promising treatment options with tirzepatide for Japanese individuals with obesity disease
1个月前
已完结
GLP-1 receptor agonists: even for kidney transplant recipients with pre-existing diabetes?
1个月前
已关闭
Compassionate care in obesity management: reclaiming humanity in health care
1个月前
已关闭
皖公网安备34019202002308
